WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) shares saw strong trading volume on Tuesday . 2,496 shares changed hands during trading, an increase of 18% from the previous session’s volume of 2,124 shares.The stock last traded at $22.87 and had previously closed at $21.61.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, WuXi AppTec presently has an average rating of “Moderate Buy”.
Get Our Latest Stock Report on WuXi AppTec
WuXi AppTec Stock Up 5.1%
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Further Reading
- Five stocks we like better than WuXi AppTec
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
- Reddit’s U.S. User Decline Raises a Bigger Question After Its Earnings Beat
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
